ARCHIVES

OPR Reinstates Duke Medical Center’s License To Conduct Human Studies

This article is from The Cancer Letter archive.

Vol. 25 No. 21 | May 28, 1999

Download PDF Visit The Full Archive

Related Articles

NCI, Private Groups, Promote Mammograms To Blacks, Hispanics

April 25, 1992

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

November 19, 2010

DeVita takes Over As NCI Acing Director; Search Begins For New Permanent Chief

January 4, 1980

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

ASTRO Members Approve Governance, Dues Changes

January 17, 2003